<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.

pmid: 19169411
pmc: PMC2629736
Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.
Common genetic variation in the complement component 1 inhibitor gene (SERPING1) was recently reported to increase the risk of developing age-related macular degeneration (AMD). This study was performed to replicate the association between SERPING1 and AMD.Seven single nucleotide polymorphisms (SNPs) tagging common haplotypes across SERPING1 were genotyped on 786 (The Mayo Clinic) subjects and the association with AMD studied using single SNP and haplotype association analyses. The SNP in intron 6 (rs2511989) previously reported to increase the risk of AMD was studied in an additional 1,541 subjects from the Age-Related Eye Disease Study (AREDS). Association with specific subtypes of AMD and interaction with four other loci: complement factor H (CFH), age-related maculopathy susceptibility 2 (ARMS2/LOC387715), High Temperature Requirement Factor A1 (HTRA1), complement factor B/complement component 2 (CFB/C2), and complement component 3 (C3) involved in AMD was explored.The seven tag-SNPs were not associated with AMD in the Mayo subjects (p=0.13-0.70) and rs2511989 was also not associated with AMD in the Mayo or AREDS subjects (p=0.44-0.45). Evaluation of haplotypes across SERPING1 did not reveal association with AMD (p=0.14-0.97). SNPs were not associated with AMD subtypes (early, geographic atrophy, or exudation). No interaction with other AMD risk variants was observed.We were unable to replicate the reported association between SERPING1 and AMD in two independent groups of subjects.
- Mayo Clinic United States
- Mayo Clinic United States
Aged, 80 and over, Male, Reproducibility of Results, Complement C1 Inactivator Proteins, Polymorphism, Single Nucleotide, Linkage Disequilibrium, Macular Degeneration, Haplotypes, Humans, Female, Genetic Predisposition to Disease, Complement C1 Inhibitor Protein, Aged
Aged, 80 and over, Male, Reproducibility of Results, Complement C1 Inactivator Proteins, Polymorphism, Single Nucleotide, Linkage Disequilibrium, Macular Degeneration, Haplotypes, Humans, Female, Genetic Predisposition to Disease, Complement C1 Inhibitor Protein, Aged
12 Research products, page 1 of 2
- 2017IsRelatedTo
- 2009IsAmongTopNSimilarDocuments
- 2015IsAmongTopNSimilarDocuments
- 2010IsAmongTopNSimilarDocuments
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2015IsAmongTopNSimilarDocuments
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).37 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%